Hyderabad, July 25 -- Laurus Labs, a leading research and development driven pharmaceutical and biotech company in India, on Friday posted a net profit of Rs 163 crore in Q1FY26, up 1154 per cent Y-o-Y as compared to Rs 13 crore in the same period last year.
Revenue during the period increased by 31 percent to Rs 1,570 crore as against Rs 1195 crore during the corresponding period in the previous year, the Hyderabad-based Pharma company said in a release here.
Commenced construction of new Gene/ADC facility in Hyderabad (Telangana) while Fermentation manufacturing site (Vizag) build up on track as planned and expect the
facility to commence operations by 2026 end, the release said.
Dr. Satyanarayana Chava, Founder & Chief Executive Offi...